Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed with Childhood Brain Tumour or Leukaemia

From Cancer Guidelines Wiki
NHMRC logo.jpg

The guideline recommendations were approved by the Chief Executive Officer of the National Health and Medical Research Council on 23 November, 2020 under section 14A of the National Health and Medical Research Council Act 1992. expand arrow

In approving the guideline recommendations, National Health and Medical Research Council (NHMRC) considers that they meet the NHMRC standard for clinical practice guidelines. This approval is valid for a period of five years.

NHMRC is satisfied that the guideline recommendations are systematically derived, based on the identification and synthesis of the best available scientific evidence, and developed for health professionals practising in an Australian health care setting.

This publication reflects the views of the authors and not necessarily the views of the Australian Government.

Publication date
December 2020, Recommended Update: 2025

Dr Kimberley Docking, The University of Sydney, Faculty of Medicine and Health, Sydney School of Health Sciences
Email: kimberley.docking(at)

About this guideline[edit source]

Plain English summary[edit source]

Executive summary[edit source]

Purpose and scope[edit source]

Background[edit source]

Clinical Questions[edit source]

Appendices[edit source]

Organisations involved in producing the guideline:
CBTL UoS-logo.png
CBTL NeuroKids logo.jpg
CBTL NSW Canc Inst logo.jpg
CBTL MCRI Logo.jpg
CBTL CCFC logo.png
CBTL Melb logo.png
CBTL BSU-logo.jpg
CBTL vub logo.jpg
CBTL ULB logo.jpg

Back to top